Does Melatonin Cause Heart Disease - What You Need to Know

Does Melatonin Cause Heart Disease  - What You Need to Know

If you’ve seen headlines linking melatonin to a higher risk of heart failure[1], you’re not alone, and yes, it sounds scary. But before we toss every melatonin bottle in the bin, let’s pause. What did the study actually show? What didn’t it show? And why does a micro-dose (as found in our Real Sleep formula) behave very differently from the multi-milligram “megadose” most people picture when they hear melatonin? It’s also worth noting that several peer-reviewed studies have pointed the other way—toward possible cardioprotective effects[2]—so this new analysis deserves a calm, careful read. With that context, let’s dig into the details.

What the study really found (and didn’t)

The study driving the melatonin scare was a retrospective look at health records from adults with insomnia. Researchers compared people who had documented melatonin use for 12+ months with similar patients who didn’t. The long-term users showed higher rates of heart failure, and death over about five years. But here’s the key: observational snapshots can’t prove cause and effect. People who take higher-dose melatonin (often 3 mg and up) for long stretches tend to have tougher insomnia, more stress, and more medical baggage, factors that independently raise heart risk. The authors and outside experts acknowledged these limitations and labeled the findings preliminary until a peer-reviewed paper is published.[3].

Understanding melatonin - the dusk signal

Melatonin is your body’s sundown messenger. In healthy rhythms, the pineal gland releases a whisper of this hormone as evening darkens; that whisper opens the gate to sleep rather than knocking you out. When we supplement, the goal is to mimic that whisper, not shout over it. That’s why dose makes all the difference.

§ Physiologic range: About 0.1–0.3 mg (100–300 mcg) reproduces typical nighttime blood levels[4], more like dimming a lamp than turning on as flood light.

§ Pharmacologic range: 1–5 mg (and higher) can drive melatonin up to 100× that of normal levels, for hours[5]. That can be useful in select cases (e.g., jet lag timing), but it’s overkill for most nightly sleep support.

The new product, LeafSource® Real Sleep provides 333 mcg (0.333 mg) per serving, right at the edge of the physiologic zone. In practice, that’s still a whisper, not a shout: you’re nudging your internal clock into its evening groove rather than clubbing receptors and risking next-morning fog.

Not all melatonin bottles tell the truth

Here’s the plain truth: some melatonin products—especially in the U.S., where rules are looser than in Canada—don’t match their labels. When independent labs tested popular brands, they found some bottles had almost no melatonin, while others had nearly five times more than listed. Even worse, a few contained serotonin, which isn’t supposed to be there at all[6].

Think of it like a volume knob that jumps from 1 to 10 every time you touch it, you can’t set a calm, steady signal. And if you can’t trust the amount, you can’t micro-dose with precision. That’s why a verified 333 mcg matters: the dose has to be what it says to deliver that gentle, “dimmer-switch” physiologic effect you want[7].

Melatonin timing matters

If dose is the what, timing is the when, and melatonin is exquisitely sensitive to it. Taken in the early evening, a small dose helps set your internal clock so sleepiness arrives on cue (this is the same clockwork that makes melatonin useful for jet lag). Take it at the wrong time, and you can nudge the clock the wrong way[8]. That’s why it’s best to micro-dose 2–3 hours before your target bedtime, while dimming screens and reducing blue light, think of it like setting the dinner table before guests arrive, not after they’ve eaten[9].

So what’s a safe dose?

Your brain naturally makes melatonin every night. Topping up with a physiologic-size signal—think hundreds of micrograms—is very different from milligram-level doses that can overwhelm receptors. Reviews of human studies suggest that low to moderate doses are generally well-tolerated, while also calling for stronger, longer-term trials. especially at higher doses used chronically[10]. A nightly 333 mcg dose sits squarely in that physiologic zone, meant to support circadian timing (the body’s “dusk cue”) rather than sedate you like a sleeping pill[11].

What to understand from the new study

§ It’s a signal, not a verdict. The study links long-term melatonin use (as recorded in medical charts) with higher heart risks in people who already had insomnia. But it does not prove that melatonin caused those problems. Big unknowns remain, like what doses people actually took and how the melatonin users differed in health from non-users to begin with.

§ Stick to proven sleep habits first. If you’ve had trouble sleeping for months, the most effective, first-line approach is a skills-based program that teaches your body to sleep again (called Cognitive Behavioral Therapy for Insomnia, or CBT-I). Think of it as sleep physical therapy: it resets routines, light exposure, and thoughts that keep you up. Supplements can help, but they should support good sleep habits, not replace them[12].

Practical takeaways for Real Sleep

§ Start low, stay precise. A 333 mcg micro-dose keeps you close to nature’s own volume, steady enough to anchor your body clock without receptor “shouting.”

§ Time it right. Take it in the early evening (about 2–3 hours before your target bedtime) and dim bright light. Dose + darkness is the circadian duet that tells your brain; “night is coming.”

§ Mind the basics. Keep the bedroom cool and dark; set a caffeine curfew (no late-day coffee/tea/energy drinks); and stick to a consistent wake time. If sleep troubles persist, consider a skills-based sleep program (like CBT-I), think of it as physical therapy for your sleep.

§ If you have heart disease or take multiple medications, check in with your clinician.

Remember: This study is a yellow light, not a red one. For most adults, a **reliable, physiologic micro-dose like 333 mcg—taken at the right time—**is a thoughtful way to support the body’s own circadian signal. It’s the difference between whispering “time for bed” and blasting a bullhorn. When it comes to setting your internal nightfall, the whisper wins. Cheers to getting REAL SLEEP!

References



[1] American Heart Association. (2025, November 3). Long-term use of melatonin supplements to support sleep may have negative health effects (AHA Scientific Sessions 2025, research abstract; preliminary, not peer-reviewed). https://newsroom.heart.org

[2] Domínguez-Rodríguez, A., Abreu-González, P., Reiter, R. J., & Kheifets, V. (2021). Melatonin and cardioprotection in humans: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 8, 635083. https://doi.org/10.3389/fcvm.2021.635083

[3] Gooneratne, N. S., et al. (2012). Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults. Journal of Pineal Research, 52(4), 437–445. https://doi.org/10.1111/j.1600-079X.2011.00958.x

[4] Zhdanova, I. V., et al. (2001). Melatonin treatment for age-related insomnia. Journal of Clinical Endocrinology & Metabolism, 86(10), 4727–4730. https://doi.org/10.1210/jcem.86.10.7901

[5] Sack, R. L., et al. (1997). Sleep-promoting effects of melatonin: At what dose, in whom, under what conditions, and by what mechanisms? Sleep, 20(10), 908–915. https://doi.org/10.1093/sleep/20.10.908

[6] Erland, L. A. E., & Saxena, P. K. (2017). Melatonin natural health products and supplements: Presence of serotonin and significant variability of melatonin content. Journal of Clinical Sleep Medicine, 13(2), 275–281. https://doi.org/10.5664/jcsm.6462

[7] Lewy, A. J., et al. (1992). Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiology International, 9(5), 380–392. https://pubmed.ncbi.nlm.nih.gov/1394610/

[8] Lewy, A. J., Ahmed, S., Jackson, J. M., & Sack, R. L. (1992). Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiology International, 9(5), 380–392. https://pubmed.ncbi.nlm.nih.gov/1394610/

[9] Brainard, G. C., et al. (2001). Action spectrum for melatonin regulation in humans: Evidence for a novel circadian photoreceptor. The Journal of Neuroscience, 21(16), 6405–6412. https://doi.org/10.1523/JNEUROSCI.21-16-06405.2001

[10] Andersen, L. P. H., Gögenur, I., Rosenberg, J., & Reiter, R. J. (2016). The safety of melatonin in humans. Clinical Drug Investigation, 36(3), 169–175. https://doi.org/10.1007/s40261-015-0368-5

[11] Zhdanova, I. V., et al. (2001). Melatonin treatment for age-related insomnia. Journal of Clinical Endocrinology & Metabolism, 86(10), 4727–4730. https://doi.org/10.1210/jcem.86.10.7901

[12] Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017). Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults. Journal of Clinical Sleep Medicine, 13(2), 307–349. https://doi.org/10.5664/jcsm.6470


Older post Newer post